Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADCY9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM121 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAF3IP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF2BP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTBD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FSD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GUSBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIDT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENPP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGPAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on